Details of the Drug

General Information of Drug (ID: DMZSL7H)

• Drug Name: 1,2-bis(2,3,4-trifluorophenyl)-2-hydroxyethanone
• Synonyms: CHEMBL244631; 1,2-bis(2,3,4-trifluorophenyl)-2-hydroxyethanone

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 0:
  Molecular Weight (mw); 320.19
  Logarithm of the Partition Coefficient (xlogp); 3.3
  Rotatable Bond Count (rotbonds); 3
  Hydrogen Bond Donor Count (hbonddonor); 1
  Hydrogen Bond Acceptor Count (hbondacc); 8
• Chemical Identifiers:
  Formula: C14H6F6O2
  IUPAC Name: 2-hydroxy-1,2-bis(2,3,4-trifluorophenyl)ethanone
  Canonical SMILES: C1=CC(=C(C(=C1C(C(=O)C2=C(C(=C(C=C2)F)F)F)O)F)F)F
  InChI: InChI=1S/C14H6F6O2/c15-7-3-1-5(9(17)11(7)19)13(21)14(22)6-2-4-8(16)12(20)10(6)18/h1-4,13,21H
  InChIKey: ICSVRGYUGLAIDB-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 16745302
  TTD ID: D06GYH

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Liver carboxylesterase (CES1)	TTMF541	EST1_HUMAN	Inhibitor	[1]

Molecular Expression Atlas of This Drug

• The Studied Disease: Discovery agent
• ICD Disease Classification: N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Liver carboxylesterase (CES1)	DTT	CES1	3.82E-08	1.86	1.9

References

• [1] Analysis of the inhibition of mammalian carboxylesterases by novel fluorobenzoins and fluorobenzils. Bioorg Med Chem. 2007 Jun 1;15(11):3801-17.